Trace Elements and Electrolytes, Volume 25 - 1st Quarter (31 - 34)

Improvement of hypertension-induced diastolic dysfunction under sustained released dipyridamole
B. Gremmler1,4, K. Kisters2, M. Hausberg3, M. Kunert1, L.J. Ulbricht1,4
1 Department of Cardiology, Marienhospital Bottrop, 2 Department of Medicine, St. Anna Hospital Herne, 3 AKTE Arbeitskreis Trace Elements and Electrolytes, 4 University of Witten/Herdecke, Germany

Add to Cart  

 

DOI 10.5414/TEP25031

Abstract

Background: Abnormalities of diastolic function are first signs of cardiac remodeling in hypertension. Despite sufficient long-term antihypertensive treatment, a diastolic dysfunction concerning left ventricular relaxation is observed in many cases. Doppler echocardiography has become well-accepted as reliable, reproducible and a practical noninvasive method for diagnosis and longitudinal follow-up of patients with these diastolic dysfunctions. Since it was shown that dipyridamole treatment increased vasodilatorstimulated phosphoprotein Ser239phosphorylation (VASP), a benefit concerning diastolic dysfunction could be indirectly possible by dipyridamole-induced endothelial resistance reduction. Methods: Prospective observation of 11 long-term successfully pretreated, hypertensive patients with abnormal relaxation in the mitral inflow velocity curve. Patients with coronary artery disease, reduced cardiac ejection fraction, disease of valves or E-F deceleration time lower than 240 ms were excluded. The measurement of the ratio between peak early flow velocity (E) and peak late transmitral flow velocity (A) (E/A ratio) was carried out before and under additional dipyridamole treatment (200 mg sustained release twice daily). There was no change of continual antihypertensive medication during the observation time (12.6 ± 4.7 d). Results: A significant amelioration of the E/A ratio from 0.68 ± 0.11 to 0.81 ± 0.12 was observed (p = 0.017). No relevant change of blood pressure values was registered. Discussion: The additional treatment of sustained release dipyridamole to the continual antihypertensive medication shows a significant improvement of diastolic dysfunction already in a small patient group. This improvement was demonstrated by analysis of Doppler-echographic measurement (E/A ratio). Since there was no affect concerning blood pressure behavior, a greater clinical observation may be justified.

Author Details

Authors

Departments

  • 1 Department of Cardiology, Marienhospital Bottrop,
  • 2 Department of Medicine, St. Anna Hospital Herne,
  • 3 AKTE Arbeitskreis Trace Elements and Electrolytes,
  • 4 University of Witten/Herdecke, Germany

Address

Dr. med. B. Gremmler, PD Dr. med. L.J. Ulbricht
Marienhospital, Josef-Albers-Straße 70, 46236 Bottrop
Email: dr.bernhard.gremmler@ t-online.de

Citation

B. Gremmler, K. Kisters, M. Hausberg, M. Kunert and L.J. Ulbricht.Improvement of hypertension-induced diastolic dysfunction under sustained released dipyridamole. 2008; 25: 31-34. doi: 10.5414/TEP25031.

###article_not_exists_msg###

Shopping Overview

Shopping Overview
Type Qtty Discount VAT Price
Your basket is empty
View Cart